Abcellera Biologics shares owned by Barclays
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Abcellera Biologics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $155k | 31k | 5.03 |
| 2025-06-30 | $148k | 43k | 3.44 |
| 2025-03-31 | $94k | 42k | 2.24 |
| 2024-12-31 | $112k | 38k | 2.92 |
| 2024-09-30 | $58k | 22k | 2.60 |
| 2024-06-30 | $62k | 21k | 2.98 |
| 2024-03-31 | $780k | 172k | 4.53 |
| 2023-12-31 | $689k | 121k | 5.71 |
| 2023-09-30 | $97k | 21k | 4.63 |
| 2023-06-30 | $3.4M | 526k | 6.44 |
| 2023-03-31 | $3.9M | 521k | 7.54 |
| 2022-12-31 | $3.2M | 317k | 10.12 |
| 2022-09-30 | $2.3M | 236k | 9.89 |
| 2022-06-30 | $2.6M | 241k | 10.64 |
| 2022-03-31 | $2.5M | 248k | 10.00 |